Survival in portopulmonary hypertension: Mayo Clinic experience categorized by treatment subgroups

American Journal of Transplantation

Volumn 8, Issue 11, 2008, Pages 2445-2453

  Swanson, K L ^a   Wiesner, R H ^a   Nyberg, S L ^a   Rosen, C B ^a   Krowka, M J ^a  

^a MAYO CLINIC   (United States)

Author keywords

Liver transplantation; Portal hypertension; Pulmonary hypertension; Right heart catheterization

Indexed keywords

PROSTACYCLIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HEMODYNAMICS; HUMAN; LIVER DISEASE; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PATIENT SELECTION; PORTOPULMONARY HYPERTENSION; PRIORITY JOURNAL; SCHOOL CHILD; SURVIVAL; TREATMENT RESPONSE;

ADOLESCENT; ADULT; AGED; CHILD; ECHOCARDIOGRAPHY; EPOPROSTENOL; FEMALE; HEART CATHETERIZATION; HEMODYNAMICS; HUMANS; HYPERTENSION, PULMONARY; LIVER DISEASES; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PRESSURE;

EID: 53749103602     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2008.02384.x     Document Type: Article

References (21)

1. Krowka MJ, Frantz RP, McGoon MD, Severson C, Plevak DJ, Wiesner RH. Improvement in pulmonary hemodynamics during intravenous epoprostenol (prostacyclin): A study of 15 patients with moderate to severe portopulmonary hypertension. Hepatology 1999 30 : 641 648.
2. Kuo PC, Plotkin JS, Johnson LB et al. Distinctive clinical features of portopulmonary hypertension. Chest 1997 112 : 980 986.
3. Simonneau G, Galie N, Rubin LJ et al. Clinical classification of pulmonary hypertension. J Am Coll Cardiol 2004 43 (12 Suppl S 5S 12S.
4. Benjaminov FS, Prentice M, Sniderman KW, Siu S, Liu P, Wong F. Portopulmonary hypertension in decompensated cirrhosis with refractory ascites. Gut 2003 52 : 1355 1362.
5. Krowka MJ, Plevak DJ, Findlay JY, Rosen CB, Wiesner RH, Krom RA. Pulmonary hemodynamics and perioperative cardiopulmonary-related mortality in patients with portopulmonary hypertension undergoing liver transplantation. Liver Transplant 2000 6 : 443 450.
6. Hadengue A, Benhayoun MK, Lebrec D, Benhamou JP. Pulmonary hypertension complicating portal hypertension: Prevalence and relation to splanchnic hemodynamics. Gastroenterology 1991 100 : 520 528.
7. Herve P, Lebrec D, Brenot F et al. Pulmonary vascular disorders in portal hypertension. Eur Respir J 1998 11 : 1153 1166.
8. Krowka MJ, Mandell MS, Ramsay MA et al. Hepatopulmonary syndrome and portopulmonary hypertension: A report of the multicenter liver transplant database. Liver Transplant 2004 10 : 174 182.
9. Mandell MS, Krowka MJ. Formation of a national database on pulmonary hypertension and hepatopulmonary syndrome in chronic liver disease. Anesthesiology 1997 87 : 450 451.
10. Krowka MJ, Swanson KL, Frantz RP, McGoon MD, Wiesner RH. Portopulmonary hypertension: Results from a 10-year screening algorithm. Hepatology 2006 44 : 1502 1510.
11. Colle IO, Moreau R, Godinho E et al. Diagnosis of portopulmonary hypertension in candidates for liver transplantation: A prospective study. Hepatology 2003 37 : 401 409.
12. Rodriguez-Roisin R, Krowka MJ, Herve P, Fallon MB. Pulmonary-Hepatic Vascular Disorders Scientific Committee ERS Task Force. Eur Respir J 2004 24 : 861 880.
13. Kawut SM, Taichman DB, Ahya VN et al. Hemodynamics and survival of patients with portopulmonary hypertension [see comment]. Liver Transplant 2005 11 : 1107 1111.
14. Reichenberger F, Voswinckel R, Steveling E et al. Sildenafil treatment for portopulmonary hypertension. Eur Respir J 2006 28 : 563 567.
15. Hoeper MM, Seyfarth HJ, Hoeffken G et al. Experience with inhaled iloprost and bosentan in portopulmonary hypertension. Eur Respir J 2007 30 : 1096 1102.
16. Ashfaq M, Chinnakotla S, Rogers L et al. The impact of treatment of portopulmonary hypertension on survival following liver transplantation. Am J Transplant 2007 7 : 1258 1264.
17. Fix OK, Bass NM, De Marco T, Merriman RB. Long-term follow-up of portopulmonary hypertension: Effect of treatment with epoprostenol. Liver Transpl 2007 13 : 875 885.
18. Sussman N, Kaza V, Barshes N et al. Successful liver transplantation following medical management of portopulmonary hypertension: A single-center series. Am J Transplant 2006 6 : 2177 2182.
19. Krowka MJ, Fallon MB, Mulligan DC, Gish RG. Model for end-stage liver disease (MELD) exception for portopulmonary hypertension. Liver Transpl 2006 12 (Suppl S114 S116.
20. Austin MJ, McDougall NI, Wendon JA et al. Safety and efficacy of combined use of sildenafil, bosentan, and iloprost before and after liver transplantation in severe portopulmonary hypertension. Liver Transpl 2008 14 : 287 291.
21. Grannas G, Neipp M, Hoeper MM et al. Indications for and outcomes after combined lung and liver transplantation: A single-center experience on 13 consecutive cases. Transplantation 2008 85 : 524 531.